Krensavage Asset Management, LLC Buys Regeneron Pharmaceuticals Inc, Taro Pharmaceutical Industries, Alkermes PLC, Sells Gilead Sciences Inc, Elanco Animal Health Inc, Biogen Inc

• New Purchases: REGN, TARO, ALKS, ANAB,
• Added Positions: ALXN,
• Reduced Positions: GILD, BIIB, UTHR, MCK, IVC, RTIX, ENTA,
• Sold Out: ELAN, AVNS,

For the details of Krensavage Asset Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/krensavage+asset+management%2C+llc/current-portfolio/portfolio

1. United Therapeutics Corp (UTHR) - 460,944 shares, 13.85% of the total portfolio. Shares reduced by 14.65%
2. Regeneron Pharmaceuticals Inc (REGN) - 104,420 shares, 13.38% of the total portfolio. New Position
3. McKesson Corp (MCK) - 254,330 shares, 12.00% of the total portfolio. Shares reduced by 13.29%
4. Alexion Pharmaceuticals Inc (ALXN) - 313,556 shares, 11.57% of the total portfolio. Shares added by 22.96%
5. Biogen Inc (BIIB) - 109,904 shares, 11.13% of the total portfolio. Shares reduced by 37.81%

Krensavage Asset Management, LLC initiated holding in Regeneron Pharmaceuticals Inc. The purchase prices were between $274.13 and $376.51, with an estimated average price of $338.52. The stock is now traded at around $399.55. The impact to a portfolio due to this purchase was 13.38%. The holding were 104,420 shares as of .

Krensavage Asset Management, LLC initiated holding in Taro Pharmaceutical Industries Ltd. The purchase prices were between $74.18 and $97.92, with an estimated average price of $84.67. The stock is now traded at around $72.92. The impact to a portfolio due to this purchase was 10.2%. The holding were 339,819 shares as of .

Krensavage Asset Management, LLC initiated holding in Alkermes PLC. The purchase prices were between $17.29 and $21.74, with an estimated average price of $19.94. The stock is now traded at around $17.77. The impact to a portfolio due to this purchase was 6.3%. The holding were 905,078 shares as of .

Krensavage Asset Management, LLC initiated holding in AnaptysBio Inc. The purchase prices were between $10.18 and $38.96, with an estimated average price of $23.27. The stock is now traded at around $15.29. The impact to a portfolio due to this purchase was 2.44%. The holding were 440,409 shares as of .

Krensavage Asset Management, LLC added to a holding in Alexion Pharmaceuticals Inc by 22.96%. The purchase prices were between $94.84 and $115.45, with an estimated average price of $107.27. The stock is now traded at around $102.56. The impact to a portfolio due to this purchase was 2.16%. The holding were 313,556 shares as of .

Krensavage Asset Management, LLC sold out a holding in Elanco Animal Health Inc. The sale prices were between $25.29 and $29.45, with an estimated average price of $27.23.

Krensavage Asset Management, LLC sold out a holding in Avanos Medical Inc. The sale prices were between $31.89 and $47.34, with an estimated average price of $36.15.